ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 33 filers reported holding ONCOSEC MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $33,000 | -38.9% | 67,398 | -7.5% | 0.00% | – |
| Q2 2022 | $54,000 | -3.6% | 72,898 | +48.8% | 0.00% | – |
| Q1 2022 | $56,000 | -76.6% | 48,998 | -80.4% | 0.00% | – |
| Q4 2021 | $239,000 | +8.1% | 249,361 | +140.0% | 0.00% | – |
| Q3 2021 | $221,000 | -79.9% | 103,898 | -73.5% | 0.00% | -100.0% |
| Q2 2021 | $1,100,000 | -32.3% | 391,505 | +14.9% | 0.00% | -50.0% |
| Q1 2021 | $1,625,000 | -21.0% | 340,706 | +6.8% | 0.00% | 0.0% |
| Q4 2020 | $2,057,000 | +51.1% | 318,906 | -20.8% | 0.00% | +100.0% |
| Q3 2020 | $1,361,000 | +87.0% | 402,722 | +13.4% | 0.00% | 0.0% |
| Q2 2020 | $728,000 | +141.1% | 355,053 | +49.4% | 0.00% | – |
| Q1 2020 | $302,000 | -15.9% | 237,583 | +19.7% | 0.00% | – |
| Q4 2019 | $359,000 | +98.3% | 198,519 | +116.5% | 0.00% | – |
| Q3 2019 | $181,000 | – | 91,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandbox Financial Partners, LLC | 75,000 | $484,000 | 0.44% |
| Avidity Partners Management LP | 1,952,000 | $12,590,000 | 0.41% |
| One68 Global Capital, LLC | 22,261 | $144,000 | 0.29% |
| J. Goldman & Co LP | 521,820 | $3,366,000 | 0.17% |
| SALZHAUER MICHAEL | 27,303 | $176,000 | 0.12% |
| 683 Capital Management, LLC | 124,191 | $801,000 | 0.04% |
| D.A. DAVIDSON & CO. | 118,000 | $761,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 106,226 | $685,000 | 0.01% |
| Sigma Planning Corp | 32,802 | $212,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,408 | $132,000 | 0.01% |